Filters: Author is Paltiel, A David [Clear All Filters]
"Paltiel Letter to the Editor." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2014).
"Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection." The Journal of infectious diseases (2015). Abstract
"The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results." Vaccine 29, no. 36 (2011): 6107-12. Abstract
"Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example." Journal of acquired immune deficiency syndromes (1999) 46, no. 1 (2007): 78-90. Abstract
"Price, performance, and the FDA approval process: the example of home HIV testing." Medical decision making : an international journal of the Society for Medical Decision Making 30, no. 2 (2010): 217-23. Abstract
"Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US." HIV clinical trials (2015): 1945577115Y0000000009. Abstract
"Projected survival gains from revising state laws requiring written opt-in consent for HIV testing." Journal of general internal medicine 26, no. 6 (2011): 661-7. Abstract
"Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection." The American journal of medicine 115, no. 8 (2003): 632-41. Abstract
"Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines." Archives of internal medicine 162, no. 8 (2002): 921-8. Abstract
"Quality of life after aortic valve replacement with tissue and mechanical implants." The Journal of thoracic and cardiovascular surgery 128, no. 2 (2004): 266-72. Abstract
"Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 49, no. 10 (2009): 1570-8. Abstract
"Rapid HIV testing at home: does it solve a problem or create one?" Annals of internal medicine 145, no. 6 (2006): 459-62. Abstract
"Reducing sexual violence by increasing the supply of toilets in khayelitsha, South Africa: a mathematical model." PloS one 10, no. 4 (2015): e0122244. Abstract
"The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality." Journal of acquired immune deficiency syndromes (1999) 30, no. 4 (2002): 421-8. Abstract
"Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department." PloS one 6, no. 10 (2011): e25575. Abstract
"Routine HIV screening in France: clinical impact and cost-effectiveness." PloS one 5, no. 10 (2010): e13132. Abstract
"Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness." PloS one 8, no. 12 (2013): e84173. Abstract
"Routine human immunodeficiency virus testing: an economic evaluation of current guidelines." The American journal of medicine 118, no. 3 (2005): 292-300. Abstract
"Scaling up antiretroviral therapy in South Africa: the impact of speed on survival." The Journal of infectious diseases 197, no. 9 (2008): 1324-32. Abstract
"Scaling up circumcision programs in Southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission." AIDS and behavior 15, no. 5 (2011): 938-48. Abstract
"Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis." PLoS medicine 7, no. 12 (2010): e1000382. Abstract
"A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up." Chest 126, no. 6 (2004): 1875-82. Abstract
"Social costs of robbery and the cost-effectiveness of substance abuse treatment." Health economics 17, no. 8 (2008): 927-46. Abstract
"The survival benefits of AIDS treatment in the United States." The Journal of infectious diseases 194, no. 1 (2006): 11-9. Abstract
"The survival benefits of antiretroviral therapy in South Africa." The Journal of infectious diseases 209, no. 4 (2014): 491-9. Abstract
"Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference." Journal of the American College of Cardiology 40, no. 4 (2002): 603-15.
"Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 51, no. 4 (2010): 392-400. Abstract
"A therapeutic HIV vaccine: how good is good enough?" Vaccine 22, no. 29-30 (2004): 4044-53. Abstract
"Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy." Journal of acquired immune deficiency syndromes (1999) 31, no. 1 (2002): 27-37. Abstract
"What is a modest public health impact?" Archives of internal medicine 172, no. 6 (2012): 521-2; author reply 522-3.
"When to start antiretroviral therapy in resource-limited settings." Annals of internal medicine 151, no. 3 (2009): 157-66. Abstract
